A
Axsome Therapeutics D
D
AXSM
107.940
USD
-1.90
(-1.73%)
قبل الجلسة
حجم التداول
939
الربح لكل سهم
-3
العائد الربحي
-
P/E
-18
حجم السوق
5,263,737,600
الأخبار المقالات
العنوان: Axsome Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.